Safety of the colonoscope magnetic imaging device (ScopeGuide) in patients with implantable cardiac devices

Background and study aims: Use of the colonoscope magnetic imaging device (ScopeGuide, Olympus Medical Systems, Tokyo, Japan) is currently contraindicated by the manufacturer for patients with implantable cardiac devices, a group of patients that is increasing annually along with the number of colonoscopies performed in the era of colorectal cancer screening. This is the first study to examine the safety of ScopeGuide in patients with permanent pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy.

Patients and methods: Nonimplanted cardiac devices were exposed to the electromagnetic field of ScopeGuide ex vivo and assessed for evidence of interference or change in device settings. Following this, consecutive patients attending device check clinics were prospectively recruited and exposed to the ScopeGuide electromagnetic field. After an initial device check, patients underwent continuous external cardiac monitoring and device interrogation while a colonoscope was placed on the abdomen over clothing and connected to ScopeGuide to simulate colonoscopy. Patients were monitored for 2 minutes to assess for any interference. ScopeGuide was then disconnected and devices were checked for any change in settings.

Results: A total of 230 patients were invited to participate and 100 were recruited to the study. There was no evidence of interference on device leads or change in programming following exposure to the electromagnetic field generated by ScopeGuide.

Conclusion: ScopeGuide does not appear to cause interference or change in settings and is therefore likely to be safe for use in patients with implantable cardiac devices.

• References

• 1 Saunders BP, Bell GD, Williams CB et al. First clinical results with a real time, electronic imager as an aid to colonoscopy. Gut 1995; 36: 913-917
• 2 Williams CB, Saunders BP, Bell GD et al. Real-time magnetic three-dimensional imaging of flexible endoscopy. Gastrointest Endosc Clin N Am 1997; 7: 469-475
• 3 Shah SG, Brooker JC, Williams CB et al. Effect of magnetic endoscope imaging on colonoscopy performance: a randomised controlled trial. Lancet 2000; 356: 1718-1722
• 4 Shah SG, Pearson HJ, Moss S et al. Magnetic endoscope imaging: a new technique for localizing colonic lesions. Endoscopy 2002; 34: 900-904
• 5 Ellul P, Fogden E, Simpson C et al. Colonic tumour localization using an endoscope positioning device. Eur J Gastroenterol Hepatol 2011; 23: 488-491
• 6 Shergill AK, McQuaid KR, Deleon A et al. Randomized trial of standard versus magnetic endoscope imaging colonoscopes for unsedated colonoscopy. Gastrointest Endosc 2012; 75: 1031-1036
• 7 Olympus Endoscope Position Detecting Unit, UPD. ScopeGuide® Version 2 User Guide. Tokyo: Olympus; 2009
• 8 Koller W, Pahwa R, Busenbark K et al. High-frequency/unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997; 42: 292-299
• 9 Zhang J, Chen JD. Pacing the gut in motility disorders. Curr Treat Options Gastroenterol 2006; 9: 351-360
• 10 Herbison GP, Arnold EP. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database Syst Rev 2009; 02 CD004202
• 11 Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009 – a World Society of Arrhythmia’s project. Pacing Clin Electrophysiol 2011; 34: 1013-1027
• 12 Trigano A, Blandeau O, Souques M et al. Clinical study of interference with cardiac pacemakers by a magnetic field at power line frequencies. J Am Coll Cardiol 2005; 45: 896-900
• 13 “Real Life Experience of interference with Implanted Heart Devices”. Warick, UK: National Grid. Available from: http://www.emfs.info/The+Science/highfields/Pacemakers/experience/ Accessed: 6 August 2013
• 14 Code of Federal Regulations, Title 47 Telecommunications, Parts 0–199, Federal Communications Commission Rules. USA: Federal Government. Available from: http://www.ecfr.gov/cgi-bin/text-idx?sid=64f63e21c14d853c79afa96fd333ff3e&c=ecfr&tpl=/ecfrbrowse/Title47/47tab_02.tpl Accessed: 27 Mar 2013
• 15 Tiikkaja M, Aro AL, Alanko T et al. Electromagnetic interference with cardiac pacemakers and implantable cardioverter-defibrillators from low-frequency electromagnetic fields in vivo. Europace 2013; 15: 388-394
• 16 Kolb C, Schmieder S, Lehmann G et al. Do airport metal detectors interfere with implantable pacemakers or cardioverter-defibrillators?. J Am Coll Cardiol 2003; 41: 2054-2059
• 17 Corbett GD, Pugh PJ, Buttery P et al. Endoscopy and implantable devices. Frontline Gastroenterol 2012; 3: 72-75